Publication | Closed Access

Latent membrane protein 1 of Epstein–Barr virus sensitizes cancer cells to cisplatin by enhancing NF-κB p50 homodimer formation and downregulating NAPA expression

Epstein–barr VirusCancer ResearchMedicineImmunologyTumor ImmunityCancer Cell BiologyLatent MembraneImmune SurveillanceCancer CellsCancer BiologyCell BiologyCell SignalingTumor BiologyViral OncologyCancer-associated Virus